The role of endogenous peptides in the direct pathway of alloreactivity to human MHC class II molecules expressed on CHO cells

Immunological Reviews

Volumn , Issue 154, 1996, Pages 155-173

  Pawelec, Graham ^a,d   Adibzadeh, Mahdi ^a   Bornhak, Sven ^a   Friccius, Hilke ^a   Halder, Thomas ^a   Kalbacher, Hubert ^a   Li, Kun ^a   Max, Heiner ^a   Müller, Claudia ^a   Sansom, David ^b   Thiel, Falk ^a   Zeuthen, Jesper ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BATH   (United Kingdom)

^c DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HLA DR ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; EPITOPE; HLA ANTIGEN CLASS 2; PEPTIDE;

ALLOIMMUNITY; ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CHO CELL; CONTROLLED STUDY; GRAFT REJECTION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MELANOMA CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; CELL DIFFERENTIATION; HAMSTER; IMMUNOLOGY;

ANIMALS; ANTIGEN PRESENTATION; CELL DIFFERENTIATION; CHO CELLS; CRICETINAE; CYTOKINES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; HUMANS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 0030299904     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065x.1996.tb00933.x     Document Type: Review

References (53)

1. Adibzadeh, M., Friccius, H., Bornhak, S., Max, H., Hambrecht, A., Sansom, D., Kalbacher, H., Schenk, A., Pohla, H. & Pawelec, G. (1994) Role of three quantitatively dominant endogenous peptides from HLA-DRB1*0401 molecules in class II-specific alloreactivity. Transplant. Immunol. 2, 293.
2. bm12-reactive T cells. J. Exp. Med. 169, 115.
3. Braun, M. Y., McCormack, A., Webb, G. & Batchelor, J. R. (1993) Mediation of acute but not chronic rejection of MHC-incompatible rat kidney grafts by alloreactive CD4 T-cells activated by the direct pathway of sensitization. Transplantation 55, 177.
4. Charlton, B., Auchincloss, H. & Fathman, C. G. (1994) Mechanisms of transplantation tolerance. Annu. Rev. Immunol. 12, 707.
5. Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A. A., Lane, W. S. & Strominger, J. L. (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178, 27.
6. De Carli, M., Berthold, S., Fickenscher, H., Fleckenstein, I. M., Delios, M. M., Gao, Q. L., Biagiotti, R., Giudizi, M. G., Kalden, J. R., Fleckenstein, B., Romagnani, S. & Del Prete, G. (1993) Immortalization with herpesvirus saimiri modulates the cytokine secretion profile of established Th1 and Th2 human T-cell clones. J. Immunol. 151, 5022.
7. Del Prete, G., De Carli, M., Almerigogna, F., Giudizi, M. G., Biagiotti, R. & Romagnani, S. (1993) Human IL-10 is produced by both type-helper (Th1) and type-2 Helper (Th2) T-cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150, 353.
8. Ericson, M. L., Sundstrom, M., Sansom, D. M. & Charron, D. J. (1994) Mutually exclusive binding of peptide and invariant chain to major histocompatibility complex class II antigens. J. Biol. Chem. 269, 26531.
9. Garban, F., Ericson, M., Roucard, C., Rabian-Herzog, C., Teisserenc, H., Sauvanet, E., Charron, D. & Mooney, N. (1996) Detection of empty HLA class II molecules on cord blood B cells. Blood 87, 3970.
10. Geiger, M. J., Gorski, J. & Eckels, D. D. (1991) T-cell receptor gene segment utilization by HLA-DR1-alloreactive T-cell clones. J. Immunol. 147, 2082.
11. Halder, T., Pawelec, G., Kirkin, A., Zeuthen, J., Meyer, H. E. & Kalbacher, H. (1996) A peptide from the known HLA class I-restricted melanoma-specific tumor antigen gp100 is presented by HLA-DR in the melanoma cell line FM3. In: Proc. 12th Histocompatibility Workshop, St. Malo, Paris, June 3-12, 1996 (in press).
12. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B. & Sinigaglia, F. (1993) Promiscuous and allele specific anchors in HLA-DR-binding peptides. Cell 74, 197.
13. b by alloreactive cytotoxic T lymphocytes. Nature 341, 749.
14. Hilkens, C. M. U., Ver Meulen, H., Van Neerven, R. J. J., Snijdewint, F. G. M., Wierenga, E. A. & Kapsenberg, M. L. (1995) Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E(2) critically depends on interleukin-2. Eur. J. Immunol. 25, 59.
15. Hurley, C. K., Steiner, N., Wagner, A., Geiger, M. J., Eckels, D. D. & Rosen-Bronson, S. (1993) Nonrandom T-cell receptor usage in the allorecognition of HLA-DR1 microvariation. J. Immunol. 150, 1314.
16. Katz, J. F. & Sant, A. J. (1994) T cell receptor recognition of MHC class II alloantigens is highly cell type dependent. J. Immunol. 152, 1629.
17. Lechler, R. I., Heaton, T., Barber, L., Bal, V., Batchelor, J. R. & Lombardi, G. (1992) Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol. Lett. 34, 63.
18. Lechler, R. I., Lombardi, G., Batchelor, J. R., Reinsmoen, N. & Bach, F. H. (1990) The molecular basis of alloreactivity. Immunol. Today 11, 83.
19. Liu, Z., Sun, Y. K., Xi, Y. P., Hong, B., Harris, P. E., Reed, E. F., & Suciu-Foca, N. (1993a) Limited usage of T cell receptor Vβ genes by allopeptide-specific T cells. J. Immunol. 150, 3180.
20. Liu, Z., Sun, Y. K., Xi, Y. P., Maffei, A., Reed, E., Harris, P. & Suciu-Foca, N. (1993b) Contribution of direct and indirect recognition pathways to T-cell alloreactivity. J. Exp. Med. 177, 1643.
21. Max, H., Halder, T., Kalbus, M., Gnau, V., Jung, G. & Kalbacher, H. (1994) A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide. Hum. Immunol. 41, 39.
22. Mocci, S. & Coffman, R. L. (1995) Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4. J. Immunol. 154, 3779.
23. Molina, I. J. & Huber, B. T. (1990) The expression of a tissue-specific self-peptide is required for allorecognition. J. Immunol. 144, 2082.
24. Mosmann, T. R. & Coffman, R. L. (1989) Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv. Immunol. 46, 111.
25. Nickerson, P., Steurer, W., Steiger, J., Zheng, X. X., Steele, A. W. & Strom, T. B. (1994) Cytokines and the Th1/Th2 paradigm in transplantation. Curr. Opin. Immunol. 6, 757.
26. Obata, F., Tsunoda, M., Kaneko, T., Ito, K., Ito, I., Masewicz, S., Mickelson, E. M., Ollier, W. E. R., Pawelec, G., Cella, M., Ferrara, G. B. & Kashiwagi, N. (1993) Human T-cell receptor TCRAV, TCRBV, and TCRAJ sequences newly found in T-cell clones reactive with allogeneic HLA class-II antigens. Immunogenetics 38, 67.
27. Olsen, A. C., Fossum, B., Kirkin, A. F., Zeuthen, J. & Gaudernack, G. (1995) A human melanoma cell line, recognized by both HLA class I and class II restricted T cells, is capable of initiating both primary and secondary immune responses. Scand. J. Immunol. 41, 357.
28. Panina-Bordignon, P., Corradin, G., Roosnek, E., Sette, A. & Lanzavecchia, A. (1991) Recognition by class-II alloreactive T-cells of processed determinants from human serum proteins. Science 252, 1548.
29. Pawelec, G. (1993a) Cloning and propagation of human T lymphocytes. In: Tumour Immunobiology. A Practical Approach (eds. Gallagher G., Rees R. C. & Reynolds C.W. p. 131. IRL Press, Oxford.
30. Pawelec, G. (1993b) Suppressor cells in transplantation immunology: do recent advances in T cell immunobiology and cytokine networking contribute to the solution of an old conundrum? Transplant. Immunol. 1, 172.
31. Pawelec, G. & Wernet, P. (1980) Restimulation properties of human alloreactive cloned T cell lines. Dissection of HLA-D-region alleles in population studies and in family segregation analysis. Immunogenetics 11, 507.
32. Pawelec, G., Shaw, S., Ziegler, A., Müller, C. & Wernet, P. (1982) Differential inhibition of HLA-D or SB-directed secondary lymphoproliferative responses with monoclonal antibodies detecting human Ia-like determinants. J. Immunol. 129, 1070.
33. + WT31-cloned cytotoxic lymphocyte. Cell. Immunol. 113, 329.
34. Pawelec, G. P., Rehbein A., Schaudt K. & Busch, F. W. (1989) IL-4-responsive human helper T cell clones are resistant to growth inhibition by tumor necrosis factor-α. J. Immunol. 143, 902.
35. Pawelec, G., Kalbacher H., Pohla H., Boshell M., Max H., Friccius H., Adibzadeh M., Hambrecht, A. & Sansom, D. (1994) Requirements for stimulation or anergy induction in alloreactive human T cell clones. Cell. Immunol. 158, 241.
36. Pawelec, G., Obata F., Sansom D., Friccius H., Daikeler T., Adibzadeh M., Schaudt K. & Pohla H. (1995a) Analysis of MHC class II-specific T cell clones. In: MHC: A Practical Approach (eds. Fernandez N. & Butcher G), Oxford University Press, Oxford (in press).
37. Pawelec, G., Pohla, H., Schlotz, E., Rehbein, A., Schaudt, K., Hambrecht, A. & Friccius, H. (1995b) Interleukin 10 is a human T cell growth factor in vitro. Cytokine 7, 355.
38. Pawelec, G., Friccius, H., Boshell, M., Rehbein, A., Schlotz, E., Pohla, H., Schaudt, K., Sansom, D. (1995c) Human γδ T cells are resistant to anergy induction but not clonal deletion in vitro. Cell. Immunol. 162, 8.
39. Pawelec, G., Max, H., Halder, T., Bruserud, Ø., Merl, A., da Silva, P. & Kalbacher, H. (1996a). BCR/ABL leukemia oncogene fusion peptides selectively bind to certain HLA-DR alleles and can be recognized by T cells fround at low frequency in the repertoire of normal donors. Blood 88, 2118.
40. + human T cells. Transplantation (in press).
41. Raziwolf, Z., Freeman, G. J., Galvin, F., Benacerraf, B., Nadler, L. & Reiser, H. (1992) Expression and function of the murine-B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. U. S. A. 89, 4210.
42. Rötzschke, O., Falk, K., Faath, F. & Rammensee, H.-G. (1991) On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174, 1059.
43. Sad, S. & Mosmann, T. R. (1994) Single IL-2-secreting precursor CD4 T cell can develop into either Th1 or Th2 cytokine secretion phenotype. J. Immunol. 153, 3514.
44. Sansom, D. M., Wilson, A., Boshell, M., Lewis, J. & Hall, N. D. (1993) B7/CD28 but not LFA-3/CD2 interactions can provide 3rd-party co-stimulation for human T-cell activation. Immunology 80, 242.
45. Sayegh, M. H., Watschinger, B. & Carpenter, C. B. (1994) Mechanisms of T cell recognition of alloantigen. The role of peptides. Transplantation 57, 1295.
46. Sloan-Lancaster, J., Evavold, B. D. & Allen, P. M. (1993) Induction of T cell anergy by altered T cell receptor ligand on live antigen presenting cells. Nature 363, 156.
47. Steinle, A., Reinhardt, C., Jantzer, P. & Schendel, D. J. (1995) In vivo expansion of HLA-B35 alloreactive T cells sharing homologous T cell receptors: evidence for maintenance of an oligoclonally dominated allospecificity by persistent stimulation with an autologous MHC peptide complex. J. Exp. Med. 181, 503.
48. Taga, K., Cherney, B. & Tosato, G. (1993) IL-10 inhibits apoptotic cell death in human T-cells starved of IL-2. Int. Immunol. 5, 1599.
49. Vogt, A. B., Kropshofer, H., Kalbacher, H., Kalbus, M., Rammensee, H. G., Coligan, J. E. & Martin, R. (1994) Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J. Immunol. 153, 1665.
50. Warrens, A. N., Heaton, T., Sidbu, S., Lombardi, G. & Lechler, R. I. (1994) Transfected murine cells expressing HLA class II can be used to generate alloreactive human T cell clones. J. Immunol. Methods 169, 25.
51. +) T cell recognition of class II MHC molecules. J. Immunol. 154, 5153.
52. + allergen-specific T(h)2 T-cell clones. Int. Immunol. 6, 1091.
53. + T-cell clones and peripheral blood T-cells. J. Immunol. 149, 2378.